These data demonstrated that LOX is a broad inhibitor of breast cancer cell proliferation and suggest an essential role of glycolytic lactate production in promoting proliferation of the cells, especially cancer cells, in the hydrogel cultures. This evidence concerns the gene LOX and breast carcinoma.